IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 157 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $2,649,000 | -52.3% | 262,577 | -37.1% | 0.27% | -16.3% |
Q4 2019 | $5,556,000 | +68.5% | 417,407 | +8.7% | 0.32% | +103.2% |
Q3 2019 | $3,298,000 | -21.8% | 384,155 | -0.4% | 0.16% | -16.5% |
Q2 2019 | $4,218,000 | -19.7% | 385,600 | -0.7% | 0.19% | -7.4% |
Q1 2019 | $5,256,000 | +79.9% | 388,435 | +37.8% | 0.20% | +72.0% |
Q4 2018 | $2,921,000 | -45.7% | 281,910 | -3.2% | 0.12% | -25.3% |
Q3 2018 | $5,375,000 | +15.1% | 291,165 | +19.2% | 0.16% | +10.5% |
Q2 2018 | $4,671,000 | +37.1% | 244,275 | +10.7% | 0.14% | +31.2% |
Q1 2018 | $3,406,000 | +6.3% | 220,750 | +3.3% | 0.11% | +11.2% |
Q4 2017 | $3,203,000 | +71.9% | 213,680 | +80.9% | 0.10% | +66.1% |
Q3 2017 | $1,863,000 | -34.6% | 118,135 | -21.7% | 0.06% | -23.4% |
Q2 2017 | $2,848,000 | +36.1% | 150,830 | +23.0% | 0.08% | +28.3% |
Q1 2017 | $2,092,000 | -0.2% | 122,640 | -10.5% | 0.06% | +7.1% |
Q4 2016 | $2,096,000 | +52.9% | 137,100 | +58.8% | 0.06% | +47.4% |
Q3 2016 | $1,371,000 | – | 86,310 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |